Evidence map›Paper›PMID 32257385›Full record

ArticleNPJ genomic medicine2020

MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling.

Zheng-Jun Zhou, Chu-Bin Luo, Hao-Yang Xin, Zhi-Qiang Hu, Gui-Qi Zhu, Jia Li, Shao-Lai Zhou

Open access · goldAbstract read
In one paragraph

Article in NPJ genomic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Joint analysis of lncRNA mCancer cell international · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zheng-Jun Zhou *1Liver Surgery Department, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.
Chu-Bin Luo *1Liver Surgery Department, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.
Hao-Yang Xin *1Liver Surgery Department, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.
Zhi-Qiang Hu1Liver Surgery Department, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.
Gui-Qi Zhu1Liver Surgery Department, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.
Jia Li1Liver Surgery Department, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.
Shao-Lai Zhou1Liver Surgery Department, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.ORCID 0000-0002-8526-5221
Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structural variations (SVs) influence the development and progression of multiple types of cancer. The genes affected by SVs in hepatocellular carcinoma (HCC) and their contribution to tumor growth and metastasis remain unknown. In this study, through whole-genome sequencing (WGS), we identified

Indexed as

Cancer genomicsGastrointestinal cancerMetastasis

Identifiers

PMID32257385
PMCPMC7113304
OpenAlexW3014451668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.